Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Prokidney (PROK) Shares Outstanding (Weighted Average): 2021-2024

Historic Shares Outstanding (Weighted Average) for Prokidney (PROK) over the last 4 years, with Dec 2024 value amounting to $291.7 million.

  • Prokidney's Shares Outstanding (Weighted Average) rose 1.59% to $294.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $294.3 million, marking a year-over-year increase of 1.59%. This contributed to the annual value of $291.7 million for FY2024, which is 23.88% up from last year.
  • Prokidney's Shares Outstanding (Weighted Average) amounted to $291.7 million in FY2024, which was up 23.88% from $235.4 million recorded in FY2023.
  • Prokidney's Shares Outstanding (Weighted Average)'s 5-year high stood at $291.7 million during FY2024, with a 5-year trough of $31.9 million in FY2021.
  • In the last 3 years, Prokidney's Shares Outstanding (Weighted Average) had a median value of $235.4 million in 2023 and averaged $253.3 million.
  • Data for Prokidney's Shares Outstanding (Weighted Average) shows a peak YoY skyrocketed of 629.85% (in 2022) over the last 5 years.
  • Yearly analysis of 4 years shows Prokidney's Shares Outstanding (Weighted Average) stood at $31.9 million in 2021, then skyrocketed by 629.85% to $232.8 million in 2022, then rose by 1.15% to $235.4 million in 2023, then increased by 23.88% to $291.7 million in 2024.